Jing Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
-
- Epigenetics and DNA Methylation 14
- RNA modifications and cancer 8
- Endocrine and Autonomic Systems top 10%
-
- Cancer Immunotherapy and Biomarkers 7
-
- Atrial Fibrillation Management and Outcomes 5
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Diagnosis and Treatment 6
-
- Acute Ischemic Stroke Management 7
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jing Xu
95 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 447
- Molecular Biology 630
- Endocrine and Autonomic Systems 55
- Oncology 183
- Cardiology and Cardiovascular Medicine 152
Countries citing papers authored by Jing Xu
This map shows the geographic impact of Jing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xu more than expected).
Fields of papers citing papers by Jing Xu
This network shows the impact of papers produced by Jing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xu. The network helps show where Jing Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 13 | |
| 17 | 2016 | 1 | |
| 18 | 2015 | 3 | |
| 19 | 2014 | 183 | |
| 20 | [Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester]. | 2012 | 4 |
About Jing Xu
Jing Xu is a scholar working on Microbiology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Acute Ischemic Stroke Management (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). The work is most often cited by research in Cancer Research (447 citations), Molecular Biology (630 citations) and Endocrine and Autonomic Systems (55 citations). Jing Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wen Gao, Yongqian Shu, Ping Wang, Ming Zhuang, Guoping Sun, Yang Jiao, Lei Huang, Jie Ning, Fajin Dong and Ning Sun. Their work appears in journals such as Bioinformatics, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.